- Home
- Publications
-
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- L. Eugene Arnold, Michael G. Aman, A.M. Cook, Andrea N. Witwer, Kelly Lynne Hall, S. Thompson, Y. Ramadan
- Title
- Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.
- Journal
- Journal of the American Academy of Child and Adolescent Psychiatry
- Year
- 2006
- Volume
- 45
- Issue
- 10
- Page(s)
- pp. 1196-1205
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Placebo, Peer-Reviewed, Cross-Over Trial, Controlled Trial
- Keywords
- Adolescent / Secondary School Age, Asperger Syndrome, Atomoxetine, Attention Deficit Hyperactivity Disorder, Attention/Concentration, Autism, Autistic Disorder, Child/Children, Hyperactivity, Intervention, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.